Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBioXcel Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

BioXcel Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.04Close · Oct 8, 2026

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Aug 12, 2026Atkins Susan E.Director17,000Stock Option (Right to Buy)—Grant / award
Jun 15, 2026Mehta VimalCEO and President219Common Stock—Exercise / conversion
Jun 15, 2026Yocca FrankChief Scientific Officer35Common Stock—Exercise / conversion
Jun 15, 2026Steinhart Richard IChief Financial Officer35Common Stock—Exercise / conversion
Jun 15, 2026Rodriguez JavierSee Remarks35Common Stock—Exercise / conversion
May 20, 2026Mehta VimalCEO and President19,419Common Stock—Sell
May 20, 2026Steinhart Richard IChief Financial Officer6,845Common Stock—Sell
May 20, 2026Rodriguez JavierSee Remarks6,560Common Stock—Sell
May 20, 2026Yocca FrankChief Scientific Officer6,845Common Stock—Sell
May 4, 2026Mehta VimalCEO and President49,758Common Stock—Exercise / conversion
…